Cold Form Blister Packaging: An Effective Choice Of Pharmaceutical Industry
Increasing healthcare products demand on account of positive outlook of pharmaceuticals & medical industries has developed the global cold form blister packaging industry. This trend is expected to continue over the forecast period. Growing end-use industries including electrical & semiconductors components, cosmetics & personal care products, and pet food, particularly in the emerging economies such as Asia Pacific is also expected to impact the global market positively.
Cold form blister packs are manufactured by sandwiching aluminum foil between Polyvinyl Chloride (PVC) and nylon (oPA) films using dry bond lamination technology. The film laminate is simply pressed into a mold by a stamp without applying heat. Thus the material is called cold forming blister laminate.
The key advantages of laminate include complete barrier for oxygen and water, thereby allowing an extended product expiry date due to a higher thickness of the foil present in the laminate. However, a major problem faced by these manufacturers is its slower speed of production as compared to thermoforming which hampers the overall supply and demand chain. Lack of transparency of the package and larger size of blister card is also one of the hurdles faced by producers.
Packaging companies are considering high quality and cost effective alternatives to manufacturing innovative, convenient packs for end-users. The cold form foils are extensively used in healthcare packaging due to its high-efficiency rate and provides extended shelf life. Advanced cold form sealing packs have also led to discovering new raw material sources with fine superior quality and easy to use. Thus, the cold forming market is projected to witness a substantial growth in the next eight years.
Cold form blister packaging is extensively used in the healthcare sector that comprises of pharmaceuticals and medical devices. It is used by pharmaceutical industry for packaging a many products including tablets, capsules, drugs, vials, ampoules, syringes or liquid products. Production of cold form foils such as push-through, peelable, peel-push, tear-open and child-resistant are based on the requirements of pharmaceuticals clients worldwide. Global blister pack manufacturers offer such tailored solutions for newly launched therapeutic areas, new processes, and other specialized healthcare applications.
“Regulatory policies drives the market growth”
Stringent regulatory policies imposed by World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMEA), and other international healthcare authorities regarding packaging and labeling are predicted to reinforce further the market growth. However, raw material availability and volatile price trends, changing health regulations and scrutinizing healthcare organizations remain bigger challenges for the global market growth
“Market Outlook”
The largest market is in Europe with a healthy growth rate and is followed by North America and then Asia Pacific which is the fastest growing market of healthcare and electronics & semiconductors. Demand from Chinese and Japanese Market is surging the growth of this market.
In-depth report on global cold form blister packaging market by Grand View Research:
https://www.grandviewresearch.com/industry-analysis/cold-form-blister-packaging-market